Literature DB >> 16604202

The multidrug transporter hypothesis of refractory epilepsy: corroboration and contradiction in equal measure.

Graeme J Sills.   

Abstract

Entities:  

Year:  2006        PMID： 16604202      PMCID： PMC1408285          DOI： 10.1111/j.1535-7511.2006.00092.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  13 in total

1.  Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells.

Authors:  Lynn W Maines; David A Antonetti; Ellen B Wolpert; Charles D Smith
Journal:  Neuropharmacology       Date:  2005-10       Impact factor: 5.250

2.  Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures.

Authors:  Holger A Volk; Wolfgang Löscher
Journal:  Brain       Date:  2005-02-16       Impact factor: 13.501

3.  Early identification of refractory epilepsy.

Authors:  P Kwan; M J Brodie
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

Review 4.  Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.

Authors:  Dieter Schmidt; Wolfgang Löscher
Journal:  Epilepsia       Date:  2005-06       Impact factor: 5.864

Review 5.  Drug resistance in brain diseases and the role of drug efflux transporters.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  Nat Rev Neurosci       Date:  2005-08       Impact factor: 34.870

6.  Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy.

Authors:  S M Sisodiya; W-R Lin; B N Harding; M V Squier; M Thom
Journal:  Brain       Date:  2002-01       Impact factor: 13.501

7.  P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice.

Authors:  Graeme J. Sills; Patrick Kwan; Elaine Butler; Elizabeth C.M. de Lange; Dirk Jan van den Berg; Martin J. Brodie
Journal:  Epilepsy Behav       Date:  2002-10       Impact factor: 2.937

8.  Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy.

Authors:  Eleonora Aronica; Jan A Gorter; Marja Ramkema; Sandra Redeker; Filiz Ozbas-Gerçeker; Edwin A van Vliet; George L Scheffer; Rik J Scheper; Paul van der Valk; Johannes C Baayen; Dirk Troost; Filiz Ozbas-Gerçerer
Journal:  Epilepsia       Date:  2004-05       Impact factor: 5.864

9.  Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy.

Authors:  Sanjay M Sisodiya; Lillian Martinian; George L Scheffer; Paul van der Valk; J Helen Cross; Rik J Scheper; Brian N Harding; Maria Thom
Journal:  Epilepsia       Date:  2003-11       Impact factor: 5.864

10.  P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats.

Authors:  Heidrun Potschka; Maren Fedrowitz; Wolfgang Löscher
Journal:  Neurosci Lett       Date:  2002-07-26       Impact factor: 3.046
View more
  2 in total

1.  Breakthrough seizures-Further analysis of the Standard versus New Antiepileptic Drugs (SANAD) study.

Authors:  Laura J Bonnett; Graham A Powell; Catrin Tudur Smith; Anthony G Marson
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

2.  Time to 12-month remission and treatment failure for generalised and unclassified epilepsy.

Authors:  Laura J Bonnett; Catrin Tudur Smith; David Smith; Paula R Williamson; David Chadwick; Anthony G Marson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-11-29       Impact factor: 10.154
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.